{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:36Z","timestamp":1792788756141,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.imlet.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T17:30:55Z","timestamp":1499189455000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Overview of immune abnormalities in lysosomal storage disorders"],"prefix":"10.1016","volume":"188","author":[{"given":"Donato","family":"Rigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.07.004_bib0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"Schultz","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.imlet.2017.07.004_bib0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1138375","article-title":"Exploring cells with a centrifuge","volume":"189","author":"de Duve","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.07.004_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"\u03b1-Glucosidase deficiency in generalized glycogen storage disease (Pompe\u2019s disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"10.1016\/j.imlet.2017.07.004_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gene.2014.09.054","article-title":"From bedside to cell biology: a century of history on lysosomal dysfunction","volume":"555","author":"Coutinho","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.imlet.2017.07.004_bib0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.imlet.2017.07.004_bib0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","article-title":"Newborn screening for lysosomal storage diseases","volume":"61","author":"Gelb","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.imlet.2017.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.031209.093756","article-title":"From serendipity to therapy","volume":"80","author":"Neufeld","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imlet.2017.07.004_bib0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.imlet.2017.07.004_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","article-title":"A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner","volume":"6","author":"Rigante","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0065","first-page":"93","article-title":"Interleukin-1: Ariadne\u2019s thread in autoinflammatory and autoimmune disorders","volume":"17","author":"Cantarini","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.imlet.2017.07.004_bib0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.autrev.2014.08.001","article-title":"The hereditary autoinflammatory disorders uncovered","volume":"13","author":"Rigante","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.07.004_bib0075","first-page":"1","article-title":"The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration","volume":"14","author":"Rigante","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.imlet.2017.07.004_bib0080","doi-asserted-by":"crossref","first-page":"38R","DOI":"10.1203\/PDR.0b013e31819dbd0a","article-title":"An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum","volume":"65","author":"McGonagle","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.imlet.2017.07.004_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2474-12-153","article-title":"Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study","volume":"12","author":"Alten","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.imlet.2017.07.004_bib0090","doi-asserted-by":"crossref","first-page":"e30123","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren\u2019s syndrome\u2014a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.07.004_bib0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4161\/auto.5227","article-title":"Lysosomal storage diseases as disorders of autophagy","volume":"4","author":"Settembre","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.imlet.2017.07.004_bib0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/978-1-4614-3209-8_78","article-title":"Sphingolipids in ocular inflammation","volume":"801","author":"Chan","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2017.07.004_bib0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5858\/2008-132-851-GDROTL","article-title":"Gaucher disease: review of the literature","volume":"132","author":"Chen","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.imlet.2017.07.004_bib0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2015.05.051","article-title":"A conserved circular network of coregulated lipids modulates innate immune responses","volume":"162","author":"K\u00f6berlin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2017.07.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2016.10.016","article-title":"Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1?","author":"Matta","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.imlet.2017.07.004_bib0125","first-page":"388","article-title":"Gaucher\u2019s disease: a disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.imlet.2017.07.004_bib0130","first-page":"205","article-title":"Cytokines in Gaucher\u2019s disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imlet.2017.07.004_bib0135","doi-asserted-by":"crossref","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in Gaucher disease: the role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.imlet.2017.07.004_bib0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcmd.2016.02.003","article-title":"Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease","volume":"59","author":"S\u00f8nder","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.imlet.2017.07.004_bib0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00005-016-0421-y","article-title":"Activated and memory T lymphocytes in children with Gaucher disease","volume":"65","author":"Zahran","year":"2017","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.imlet.2017.07.004_bib0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.humimm.2015.11.018","article-title":"CD4+CD25 high Foxp3+ Treg deficiency in a Brazilian patient with Gaucher disease and lupus nephritis","volume":"77","author":"Matta","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01541326","article-title":"Natural autoantibodies in sera of patients with Gaucher\u2019s disease","volume":"15","author":"Shoenfeld","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry\u2019s disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.07.004_bib0170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.114.009789","article-title":"Anderson-Fabry disease and other lysosomal storage disorders","volume":"130","author":"Nagueh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2017.07.004_bib0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2016.07.001","article-title":"Fabry disease: a disorder of childhood onset","volume":"64","author":"Schiffmann","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0180","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.imlet.2017.07.004_bib0185","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1590\/S1415-47572012000600009","article-title":"Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis","volume":"35","author":"Alegra","year":"2012","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_371","article-title":"Innate and adaptive immune response in Fabry disease","volume":"22","author":"Mauhin","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.imlet.2017.07.004_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.imlet.2017.07.004_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.imlet.2017.07.004_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imlet.2017.07.004_bib0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.imlet.2017.07.004_bib0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10545-007-0513-2","article-title":"High incidence of autoantibodies in Fabry disease patients","volume":"30","author":"Martinez","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.imlet.2017.07.004_bib0220","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2169\/internalmedicine.33.172","article-title":"Possible thyroidal involvement in a case of Fabry disease","volume":"33","author":"Tojo","year":"1994","journal-title":"Intern. Med."},{"key":"10.1016\/j.imlet.2017.07.004_bib0225","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1210\/jc.2006-0858","article-title":"Endocrine dysfunction in patients with Fabry disease","volume":"91","author":"Faggiano","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.imlet.2017.07.004_bib0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1297\/cpe.20.95","article-title":"Fabry disease superimposed on overt autoimmune hypothyroidism","volume":"20","author":"Katsumata","year":"2011","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000448968","article-title":"long term treatment with enzyme replacement therapy in patients with Fabry disease","volume":"134","author":"Oder","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.imlet.2017.07.004_bib0240","doi-asserted-by":"crossref","first-page":"471325","DOI":"10.1155\/2012\/471325","article-title":"Glycosaminoglycan storage disorders: a review","volume":"2012","author":"Coutinho","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.imlet.2017.07.004_bib0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00381-007-0301-1","article-title":"Gargoyle-like features in lysosomal diseases involving glycosaminoglycans","volume":"23","author":"Rigante","year":"2007","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.imlet.2017.07.004_bib0250","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.imlet.2017.07.004_bib0255","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jcjo.2013.04.010","article-title":"The great masquerade: delayed diagnosis of mucopolysaccharidosis in adulthood","volume":"48","author":"Kurniawan","year":"2013","journal-title":"Can. J. Ophthalmol."},{"issue":"Suppl. 5","key":"10.1016\/j.imlet.2017.07.004_bib0260","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.imlet.2017.07.004_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000064674","article-title":"Cardiac structural involvement in mucopolysaccharidoses","volume":"98","author":"Rigante","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.imlet.2017.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.joca.2013.08.001","article-title":"Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation","volume":"21","author":"Opoka-Winiarska","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.imlet.2017.07.004_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation: microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.imlet.2017.07.004_bib0280","doi-asserted-by":"crossref","first-page":"e0150850","DOI":"10.1371\/journal.pone.0150850","article-title":"Immune-mediated inflammation may contribute to the pathogenesis of cardiovascular disease in mucopolysaccharidosis type I","volume":"11","author":"Khalid","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.07.004_bib0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-8417-2-4","article-title":"Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI","volume":"2","author":"Tessitore","year":"2009","journal-title":"Pathogenetics"},{"key":"10.1016\/j.imlet.2017.07.004_bib0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-7-39","article-title":"Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response","volume":"7","author":"Killedar","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imlet.2017.07.004_bib0295","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jnr.21912","article-title":"Innate and adaptive immune activation in the brain of MPS IIIB mouse model","volume":"87","author":"DiRosario","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.imlet.2017.07.004_bib0300","doi-asserted-by":"crossref","first-page":"14362","DOI":"10.1073\/pnas.222536599","article-title":"Glycosaminoglycans are a potential cause of rheumatoid arthritis","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2017.07.004_bib0305","first-page":"674","article-title":"Types A and B Niemann-Pick disease","volume":"13","author":"Schuchman","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.imlet.2017.07.004_bib0310","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-4159.2010.07034.x","article-title":"Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice","volume":"116","author":"Ledesma","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.imlet.2017.07.004_bib0315","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.nbd.2011.12.027","article-title":"Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice","volume":"45","author":"Pressey","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.imlet.2017.07.004_bib0320","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2005.02.029","article-title":"Neuroglial activation in Niemann-Pick type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells","volume":"381","author":"Bae","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.imlet.2017.07.004_bib0325","first-page":"37","article-title":"Pulmonary alveolar proteinosis and Niemann Pick disease type B: an unexpected combination","volume":"19","author":"Sideris","year":"2016","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.imlet.2017.07.004_bib0330","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1177\/0961203315585818","article-title":"Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease","volume":"24","author":"Murgia","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2017.07.004_bib0335","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.jmb.2016.05.020","article-title":"Gangliosides of the vertebrate nervous system","volume":"428","author":"Schnaar","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.imlet.2017.07.004_bib0340","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibs.2015.03.007","article-title":"Gangliosides: glycosphingolipids essential for normal neural development and function","volume":"40","author":"Schengrund","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2017.07.004_bib0345","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.imlet.2017.07.004_bib0350","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4020-8831-5_17","article-title":"Glycosphingolipid disorders of the brain","volume":"49","author":"Boomkamp","year":"2008","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.imlet.2017.07.004_bib0355","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandhoff","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2017.07.004_bib0360","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI200419639","article-title":"Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses","volume":"113","author":"Yamaguchi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.07.004_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/isl.20102","article-title":"Roles of ceramide and sphingolipids in pancreatic \u03b2-cell function and dysfunction","volume":"4","author":"Boslem","year":"2012","journal-title":"Islets"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817301499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817301499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T12:46:41Z","timestamp":1659185201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817301499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":73,"alternative-id":["S0165247817301499"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.07.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of immune abnormalities in lysosomal storage disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}